Patent · US Active

Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound

US10688087B2 · kind B2 · utility

0Cited by

5References

41Claims

0Family size

Assignee

PLEDPHARMA AB · SE

Inventors

Jan-Olof Karlsson · Oslo, NO
Rolf Andersson · Vikingstad, SE

Key dates

Filing date	Jul 6, 2010
Grant date	Jun 23, 2020
Priority date	—
Expiry date	Jan 8, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition for treatment of a pathological condition in a patient comprises, as a first component, a manganese complex of Formula I( ), and, as a second component, a non-manganese complex compound of Formula (I), optionally together with one or more physiologically acceptable carriers and/or excipients, wherein X, R, R, R, and R are as defined herein. Methods for treatment of a pathological condition in a patient, for example, a pathological condition caused by the presence of oxygen-derived free radicals, comprises administering to said patient the first component and the second component.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.